Genmab A/SGMABNASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank79
3Y CAGR-2.7%
5Y CAGR+5.7%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
-2.7%/yr
vs +48.0%/yr prior
5Y CAGR
+5.7%/yr
Recent deceleration
Acceleration
-50.7pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $13.35B | -35.0% |
| 2024 | $20.54B | +26.4% |
| 2023 | $16.25B | +12.0% |
| 2022 | $14.51B | +72.3% |
| 2021 | $8.42B | -16.8% |
| 2020 | $10.11B | +88.4% |
| 2019 | $5.37B | +77.4% |
| 2018 | $3.03B | +27.9% |
| 2017 | $2.37B | +30.2% |
| 2016 | $1.82B | - |